1.0
Dec 23, 2024
Former employee, more than 5 years
Minneapolis, MN
Recommend
CEO approval
Business Outlook
Pros
Pay and benefits are decent.
Cons
Massive job cuts in early December 2024. Managers were not even aware their direct reports were being eliminated. Worker bees were cut but middle managers who don’t know how to roll up their sleeves and get their hands dirty kept their jobs. It is clear they are cutting expenses to look financially appealing to investors. The plan is to sell off divisions and focus on making the Medical/Surgical division ripe for acquisition. The CEO and about half of the executive leadership team came from Medtronic so don’t be surprised when Medtronic acquires what’s left of Solventum in the next few years.